Ticker
SRZNCompany Name
SURROZEN INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 91.08M | 15.86 | $ 5.74M |
3/31/2025 | $ 102.33M | 9.67 | $ 10.58M |
12/31/2024 | $ 35.25M | 4.82 | $ 7.32M |
9/30/2024 | $ 31.7M | 5.18 | $ 6.12M |
6/30/2024 | $ 38.45M | 6.43 | $ 5.98M |
3/31/2024 | $ 27.98M | 4.53 | $ 6.18M |
12/31/2023 | $ 36.73M | 5.14 | $ 7.15M |
9/30/2023 | $ 34.4M | 5.16 | $ 6.67M |
6/30/2023 | $ 36.9M | 5.72 | $ 6.45M |
3/31/2023 | $ 28.21M | 3.62 | $ 7.79M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for SURROZEN INC is calculated as follows: CashnEq [ $ 0 ] / LiabilitesC [ $ 30K ]
(=) Cash Ratio [ 0 ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |